60
Participants
Start Date
March 1, 2024
Primary Completion Date
July 31, 2024
Study Completion Date
September 1, 2024
Sodium Hyaluronate
Sodium Hyaluronate (Butirprost®) is a nutraceutical formulation in suppository form, designed for the management of chronic bacterial prostatitis (CBP). It contains key ingredients such as sodium hyaluronate, a derivative of hyaluronic acid (HA), along with Plantago major. Sodium hyaluronate is valued for its potent anti-inflammatory and tissue-regenerative properties, while Plantago major offers additional benefits through its soothing and wound-healing effects, enhancing the overall efficacy of the formulation in treating CBP.
Levofloxacin 500mg
Treatment typically involves fluoroquinolones alone, such as levofloxacin.
University of Naples Federico II, Napoli
Federico II University
OTHER